Clinical Trial Update: Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation [Phase 1]

View source ↗

Summary

This report updates findings from a Phase 1 trial evaluating safety of reducing immunosuppression in children and adolescents after kidney transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Transplantation

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Kidney Failure, Chronic, Kidney Transplantation | Phase 1 | Status: COMPLETED